![](/img/cover-not-exists.png)
Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks
Anforth, R., Carlos, G., Clements, A., Kefford, R., Fernandez-Peñas, P.Volume:
172
Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.13200
Date:
January, 2015
File:
PDF, 207 KB
english, 2015